STERIS plc (NYSE:STE) Q3 2024 Earnings Conference Call February 8, 2024 9:00 AM ET Company Participants Julie Winter - Vice President of Investor Relations Mike Tokich - Senior Vice President & Chief Financial Officer Dan Carestio - President & Chief Executive Officer Conference Call Participants Patrick Wood - Morgan Stanley Brett Fishbin - KeyBanc Jacob Johnson - Stephens, Inc. Michael Polark - Wolfe Research Jason Bednar - Piper Sandler Michael Matson - Needham & Company David Turkaly - JMP Securities Op ...

STERIS plc (STE) reported third-quarter fiscal 2024 adjusted earnings per share (EPS) of $2.22, up 9.9% from the year-ago quarter’s figure. The metric surpassed the Zacks Consensus Estimate by 2.8%.The adjustment excludes the impacts of certain non-recurring charges like the amortization of acquired intangible assets and acquisition and integration-related charges, among others.The company’s GAAP EPS was $1.42, an increase of 14.5% from the year-ago period.  Revenues in DetailRevenues of $1.40 billion incre ...

Steris (STE) reported $1.4 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 14.8%. EPS of $2.22 for the same period compares to $2.02 a year ago.The reported revenue represents a surprise of +4.22% over the Zacks Consensus Estimate of $1.34 billion. With the consensus EPS estimate being $2.17, the EPS surprise was +2.30%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ...

Steris (STE) came out with quarterly earnings of $2.22 per share, beating the Zacks Consensus Estimate of $2.17 per share. This compares to earnings of $2.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.30%. A quarter ago, it was expected that this medical products maker would post earnings of $2.05 per share when it actually produced earnings of $2.03, delivering a surprise of -0.98%.Over the last four quarters, the comp ...

Third quarter revenue increases 15% as reported; 10% constant currency organicAs reported diluted earnings per share increased to $1.42; adjusted earnings per share increased to $2.22Fiscal 2024 outlook updated DUBLIN, IRELAND, Feb. 07, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE:STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2024 third quarter ended December 31, 2023. Revenue as reported for the quarter increased 15% to $1.40 billion compared with $1.22 billion in the third ...

FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 Commission File Number 001-38848 STERIS plc (Exact name of registrant as specified in its charter) Ireland 98-1455064 ...

Wall Street analysts forecast that Steris (STE) will report quarterly earnings of $2.16 per share in its upcoming release, pointing to a year-over-year increase of 6.9%. It is anticipated that revenues will amount to $1.34 billion, exhibiting an increase of 10.1% compared to the year-ago quarter.The current level reflects a downward revision of 0.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their i ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Steris (STE) reports results for the quarter ended December 2023. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on February 7. On t ...

DUBLIN, IRELAND , Jan. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE:STE) ("STERIS" or the "Company") announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on March 22, 2024, to shareholders of record at the close of business on February 23, 2024. Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at www.steris-ir.com. STERIS is a leading global provider of products and services tha ...

DUBLIN, IRELAND, Jan. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 third quarter financial results at 9:00 a.m. ET on February 8, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.   A press release detailing financial results will b ...